President Joe Biden has reportedly picked former North Carolina health chief Mandy Cohen, MD, MPH, as next head of the CDC; Black men were probably underdiagnosed with lung problems because of software bias; the US birthrate remains flat.
Former NC Health Secretary Might Lead CDC
President Joe Biden plans to name Mandy Cohen, MD, MPH, the former North Carolina health and human services chief, as the next director of the CDC, reported The New York Times. Cohen, an internist, headed the department from 2017 to 2021 and formerly served in the Obama administration. If chosen, Cohen would replace Rochelle P Walensky, MD, MPH, who announced that she would step down at the end of June.
Black Men Likely Underdiagnosed Due to Bias in PFT Testing
Racial bias inherent in pulmonary function testing (PFT) is likely contributing to fewer Black patients getting care, suggests a study, according to The Associated Press. As many as 40% more Black male patients in the study, published in JAMA Network Open, might have received a diagnosis of breathing problems if current diagnosis-assisting computer software was changed to be race neutral. The findings are the latest example of faulty assumptions of algorithms used in diagnostic tests and software.
US Birthrate Flat Compared to Pre-Pandemic
The birthrate in the United States stayed flat in 2022 compared to pre-pandemic levels, according to a report from the CDC, reported The Hill. The CDC reported 3,661,220 provisional births in the United States in 2022, about 3000 fewer births than the year before. The CDC called it a “nonsignificant decline." Total birth count in 2022 also stayed below pre-pandemic levels after the birthrate slightly bounced back in 2021 following the first year of the COVID-19 pandemic.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More